230 related articles for article (PubMed ID: 20413440)
21. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis.
Pai M; Kalantri S; Dheda K
Expert Rev Mol Diagn; 2006 May; 6(3):413-22. PubMed ID: 16706743
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.
Vassilopoulos D; Stamoulis N; Hadziyannis E; Archimandritis AJ
J Rheumatol; 2008 Jul; 35(7):1271-6. PubMed ID: 18381793
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of latent tuberculosis infection in bacille Calmette-Guérin vaccinated subjects in China by interferon-gamma ELISpot assay.
Zhang M; Wang H; Liao M; Chen X; Graner M; Zhu X; Zhang J; Yang Q; Lu H; Zhou B; Chen X
Int J Tuberc Lung Dis; 2010 Dec; 14(12):1556-63. PubMed ID: 21144240
[TBL] [Abstract][Full Text] [Related]
24. Results of a tuberculosis-specific IFN-gamma assay in children at high risk for tuberculosis infection.
Tsiouris SJ; Austin J; Toro P; Coetzee D; Weyer K; Stein Z; El-Sadr WM
Int J Tuberc Lung Dis; 2006 Aug; 10(8):939-41. PubMed ID: 16898381
[TBL] [Abstract][Full Text] [Related]
25. An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.
Codecasa L; Mantegani P; Galli L; Lazzarin A; Scarpellini P; Fortis C
J Clin Microbiol; 2006 Jun; 44(6):1944-50. PubMed ID: 16757583
[TBL] [Abstract][Full Text] [Related]
26. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents.
Bergamini BM; Losi M; Vaienti F; D'Amico R; Meccugni B; Meacci M; De Giovanni D; Rumpianesi F; Fabbri LM; Balli F; Richeldi L
Pediatrics; 2009 Mar; 123(3):e419-24. PubMed ID: 19254978
[TBL] [Abstract][Full Text] [Related]
27. Identifying recent Mycobacterium tuberculosis transmission in the setting of high HIV and TB burden.
Mutsvangwa J; Millington KA; Chaka K; Mavhudzi T; Cheung YB; Mason PR; Butterworth AE; Corbett EL; Lalvani A
Thorax; 2010 Apr; 65(4):315-20. PubMed ID: 20388756
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH
Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis of latent tuberculosis infection: the potential role of new technologies.
Kunst H
Respir Med; 2006 Dec; 100(12):2098-106. PubMed ID: 16650976
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of an interferon-gamma release assay, T-SPOT.TB, in a population with a low prevalence of tuberculosis.
Bienek DR; Chang CK
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1416-21. PubMed ID: 19861016
[TBL] [Abstract][Full Text] [Related]
31. QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection.
Manuel O; Kumar D
Expert Rev Mol Diagn; 2008 May; 8(3):247-56. PubMed ID: 18598104
[TBL] [Abstract][Full Text] [Related]
32. Latent tuberculosis infections in hard-to-reach drug using population-detection, prevention and control.
Hwang LY; Grimes CZ; Beasley RP; Graviss EA
Tuberculosis (Edinb); 2009 Dec; 89 Suppl 1():S41-5. PubMed ID: 20006303
[TBL] [Abstract][Full Text] [Related]
33. Association of the level of IFN-γ produced by T cells in response to Mycobacterium tuberculosis-specific antigens with the size of skin test indurations among individuals with latent tuberculosis in a highly tuberculosis-endemic setting.
Legesse M; Ameni G; Mamo G; Medhin G; Bjune G; Abebe F
Int Immunol; 2012 Feb; 24(2):71-8. PubMed ID: 22298884
[TBL] [Abstract][Full Text] [Related]
34. Specificity of the tuberculin skin test and the T-SPOT.TB assay among students in a low-tuberculosis incidence setting.
Talbot EA; Harland D; Wieland-Alter W; Burrer S; Adams LV
J Am Coll Health; 2012; 60(1):94-6. PubMed ID: 22171735
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the interferon- gamma release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers.
Lee SS; Liu YC; Huang TS; Chen YS; Tsai HC; Wann SR; Lin HH
Scand J Infect Dis; 2008; 40(5):373-80. PubMed ID: 18418798
[TBL] [Abstract][Full Text] [Related]
36. [Difficulties of TB diagnosis in children: QuantiFERON TB Gold In-Tube as useful tool].
Grare M; Derelle J; Dailloux M; Laurain C
Arch Pediatr; 2010 Jan; 17(1):77-85. PubMed ID: 19733468
[TBL] [Abstract][Full Text] [Related]
37. High prevalence of latent tuberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test.
Lee SS; Chou KJ; Dou HY; Huang TS; Ni YY; Fang HC; Tsai HC; Sy CL; Chen JK; Wu KS; Wang YH; Lin HH; Chen YS
Clin J Am Soc Nephrol; 2010 Aug; 5(8):1451-7. PubMed ID: 20538837
[TBL] [Abstract][Full Text] [Related]
38. Clinical utility of a T cell-based assay in the diagnosis of extrapulmonary tuberculosis.
Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Oka M
Respirology; 2009 Mar; 14(2):276-81. PubMed ID: 19210655
[TBL] [Abstract][Full Text] [Related]
39. Tuberculosis infection in drug users: interferon-gamma release assay performance.
Grimes CZ; Hwang LY; Williams ML; Austin CM; Graviss EA
Int J Tuberc Lung Dis; 2007 Nov; 11(11):1183-9. PubMed ID: 17958979
[TBL] [Abstract][Full Text] [Related]
40. [Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts].
Oztürk N; Sürücüoğlu S; Ozkütük N; Gazi H; Akçali S; Köroğlu G; Ciçek C
Mikrobiyol Bul; 2007 Apr; 41(2):193-202. PubMed ID: 17682705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
